Regulatory ApprovalLucentis® biosimilar FYB201/Ranivisio® (ranibizumab) approved in Brazil 05.06.2025 / 06:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press ...

The large molecule drug substance CDMO market is anticipated to expand at a CAGR of ~9% during the forecast period. Key ...

The image-guided therapy systems market is projected to grow at a CAGR of ~5% over the forecast period. Major factors driving ...

An executive order from the Trump administration has reintroduced the “most favored nation” (MFN) policy, which aims to cut ...

The HLA typing market is projected to grow at a CAGR of ~6% over the forecast period. Major factors driving the growth ...

The point-of-care ultrasound devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors ...

The pharmaceutical excipients market is projected to grow at a CAGR of 6% from 2025 to 2030, driven by the increasing demand ...

The urology ultrasound devices market is projected to grow at a CAGR of 6%, driven by the rising prevalence of urological ...

JRM Construction Management is excited to announce the successful completion of a comprehensive renovation project of the ...

The global single-cell analysis Market is expected to witness a growth rate of 14% in the next five years. Continuous ...

The fetal monitoring bands market is experiencing steady growth, with a projected CAGR of approximately 7% over the forecast ...

The cardiac ablation market is projected to grow at a CAGR of ~13% over the forecast period. Major factors driving growth ...